All News Apeloa Pharmaceutical Co.,Ltd

Equities

000739

CNE000000Q45

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
15.55 ^CNY	-1.77%		-0.58%	+1.04%

17/04	Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
10/04	Apeloa Pharmaceutical Co.,Ltd Approves Cash Dividend for 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	17/04	CI
Apeloa Pharmaceutical Co.,Ltd Approves Cash Dividend for 2023	10/04	CI
Apeloa Pharmaceutical Co.,Ltd announces an Equity Buyback for CNY 300 million worth of its shares.	27/03	CI
Apeloa Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	27/03	CI
Apeloa Pharmaceutical Co.,Ltd. Proposes Final Dividend for 2023	09/03	CI
Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	07/03	CI
Apeloa Pharmaceutical to Co-Develop Antibody Drug Conjugates With Zhenge Biotechnology	06/03	MT
Apeloa Pharmaceutical to Scrap Sofadil for Injection Clinical Trial for Stroke	29/01	MT
Apeloa Pharmaceutical's Profit Climbs 13.6% in Q3	19/23/19	MT
Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	18/23/18	CI
Apeloa Pharmaceutical to Cooperate With Wuhan Hopson Technology on Customized Production Projects	18/23/18	MT
Apeloa Pharma Unit Passes US FDA On-Site Inspection	22/23/22	MT
Apeloa Pharmaceutical's Unit Passes US FDA's Inspection	13/23/13	MT
Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	14/23/14	CI
Apeloa Pharma Forms Strategic Drug Alliance With Zelgen Biopharma	13/23/13	MT
Apeloa Pharmaceutical to Sell 95% Stake in Injection Unit for 38 Million Yuan	19/23/19	MT
Shanxi Heyang Pharmaceutical Ltd entered into an agreement to acquire 95% stake in Shanxi Puheng Pharmaceutical Co., Ltd from Apeloa Pharmaceutical Co.,Ltd for CNY 38 million	19/23/19	CI
Apeloa Pharmaceutical Co.,Ltd Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 22 May 2023	17/23/17	CI
Apeloa Pharmaceutical Co.,Ltd Approves Election of Pan Weiguang as Independent Director	20/23/20	CI
Apeloa Pharmaceutical Co.,Ltd Approves Cash Dividend for the Year 2022	20/23/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Apeloa Pharmaceutical Co.,Ltd

Equities

000739

CNE000000Q45

All News

Filters